Andrew Salzman

CA·SEDI

Claritas Pharmaceuticals, Inc.

Cumul. flow

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (7 ops.)

€120k

Latest filing published 11 Oct 2021 for Claritas Pharmaceuticals, Inc., €22k.

Filing timeline

BuySale

Andrew Salzman

Insider track record

Disclosed buys

Disclosed sells

Signal history

Andrew Salzman: trading record in brief

All filings by Andrew Salzman on record concern Claritas Pharmaceuticals, Inc. The record holds 8 filings, for trades running from 30 December 2016 to 10 October 2021.

The open-market record consists of 7 sales worth €120k, with no purchase. So far in 2021, the count stands at no purchases and 7 sales.

The latest filing, published on 11 October 2021, reports an open-market sale of €22k in Claritas Pharmaceuticals, Inc. Typically, a trade is published a median of 49 days after it takes place. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEDI disclosures alone and does not predict where the share price will go.

Companies and markets linked to Andrew Salzman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Claritas Pharmaceuticals, Inc. (CA)

Declarations8 total

▼

Andrew Salzman

6 - Director or Senior Officer of 10% Security HolderExecutives10 Oct 2021Claritas Pharmaceuticals, Inc.

31,990 CAD13SEDI

118,000 shares@ CA$0.271118.5% of flowCommon SharesTSXSEDI:3817024

▼

Andrew Salzman

6 - Director or Senior Officer of 10% Security HolderExecutives5 Oct 2021Claritas Pharmaceuticals, Inc.

40,245 CAD13SEDI

152,500 shares@ CA$0.263923.0% of flowCommon SharesTSXSEDI:3817025

▼

Andrew Salzman

6 - Director or Senior Officer of 10% Security HolderExecutives17 Sept 2021Claritas Pharmaceuticals, Inc.

8,820 CAD11SEDI

24,500 shares@ CA$0.364.9% of flowCommon SharesTSXSEDI:3817023

▼

Andrew Salzman

6 - Director or Senior Officer of 10% Security HolderExecutives11 Aug 2021Claritas Pharmaceuticals, Inc.

12,458 CAD12SEDI

27,000 shares@ CA$0.46147.1% of flowCommon SharesTSXSEDI:3814174

▼

Andrew Salzman

6 - Director or Senior Officer of 10% Security HolderExecutives10 Aug 2021Claritas Pharmaceuticals, Inc.

13,377 CAD12SEDI

30,500 shares@ CA$0.43867.6% of flowCommon SharesTSXSEDI:3814169

▼

Andrew Salzman

6 - Director or Senior Officer of 10% Security HolderExecutives16 Aug 2021Claritas Pharmaceuticals, Inc.

14,658 CAD12SEDI

32,500 shares@ CA$0.4518.3% of flowCommon SharesTSXSEDI:3814178

▼

Andrew Salzman

6 - Director or Senior Officer of 10% Security HolderExecutives20 Aug 2021Claritas Pharmaceuticals, Inc.

54,779 CAD14SEDI

119,500 shares@ CA$0.458430.5% of flowCommon SharesTSXSEDI:3814181

●

Andrew Salzman

6 - Director or Senior Officer of 10% Security HolderExecutives30 Dec 2016Claritas Pharmaceuticals, Inc.

0SEDI

Common SharesTSXSEDI:3781443

8 of 8 declarations

Andrew Salzman: trading record in brief

All filings by Andrew Salzman on record concern Claritas Pharmaceuticals, Inc. The record holds 8 filings, for trades running from 30 December 2016 to 10 October 2021.

The open-market record consists of 7 sales worth €120k, with no purchase. So far in 2021, the count stands at no purchases and 7 sales.

Andrew Salzman

Insider track record

Andrew Salzman: trading record in brief

Companies and markets linked to Andrew Salzman

Related entities

Andrew Salzman

Insider track record

Andrew Salzman: trading record in brief

Companies and markets linked to Andrew Salzman

Related entities